Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

Yunlong Li; Pengfei Li; Yang Li; Ruyi Zhang; Peifa Yu; Zhongren Ma; Denis E. Kainov; Robert A. de Man; Maikel P. Peppelenbosch; Qiuwei Pan

doi:10.1016/j.antiviral.2020.104967

Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

Yunlong Li, Pengfei Li, Yang Li, Ruyi Zhang, Peifa Yu, Zhongren Ma, Denis E. Kainov, Robert A. de Man, Maikel P. Peppelenbosch, Qiuwei Pan

Institute for Molecular Medicine Finland

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	104967
Journal	Antiviral Research
Volume	184
Number of pages	10
ISSN	0166-3542
DOIs	https://doi.org/10.1016/j.antiviral.2020.104967
Publication status	Published - Dec 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

Cancer patients
Gemcitabine
Interferon-like response
STAT1 phosphorylation
317 Pharmacy
11832 Microbiology and virology

Access to Document

10.1016/j.antiviral.2020.104967

1-s2.0-S0166354220303818-mainFinal published version, 6.45 MBLicence: CC BY

Cite this

@article{871e7bc947b04611be20208c85281d60,

title = "Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation",

keywords = "Cancer patients, Gemcitabine, Interferon-like response, STAT1 phosphorylation, 317 Pharmacy, 11832 Microbiology and virology",

author = "Yunlong Li and Pengfei Li and Yang Li and Ruyi Zhang and Peifa Yu and Zhongren Ma and Kainov, {Denis E.} and {de Man}, {Robert A.} and Peppelenbosch, {Maikel P.} and Qiuwei Pan",

year = "2020",

month = dec,

doi = "10.1016/j.antiviral.2020.104967",

language = "English",

volume = "184",

journal = "Antiviral Research",

issn = "0166-3542",

publisher = "Elsevier Scientific Publ. Co",

}

TY - JOUR

T1 - Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation

AU - Li, Yunlong

AU - Li, Pengfei

AU - Li, Yang

AU - Zhang, Ruyi

AU - Yu, Peifa

AU - Ma, Zhongren

AU - Kainov, Denis E.

AU - de Man, Robert A.

AU - Peppelenbosch, Maikel P.

AU - Pan, Qiuwei

PY - 2020/12

Y1 - 2020/12

KW - Cancer patients

KW - Gemcitabine

KW - Interferon-like response

KW - STAT1 phosphorylation

KW - 317 Pharmacy

KW - 11832 Microbiology and virology

U2 - 10.1016/j.antiviral.2020.104967

DO - 10.1016/j.antiviral.2020.104967

M3 - Article

C2 - 33137361

SN - 0166-3542

VL - 184

JO - Antiviral Research

JF - Antiviral Research

M1 - 104967

ER -